GlassScriptPhysician profile
Gerald A Gantt
NPI 1386962207
$16,211.23
in general payments reported to CMS, 2019-2025
20 companies · $1,460 in 2025
The $1,460 reported for 2025 was more than what 78% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $943 · 2020: $408 · 2021: $1,164 · 2022: $770 · 2023: $491 · 2024: $11K · 2025: $1,460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Food and Beverage: $2,574 · Travel and Lodging: $353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,000.00 |
| Food and Beverage | $2,574.10 |
| Travel and Lodging | $352.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Virtual Incision Corporation | $10,154.00 | 2024 | Mira |
| Intuitive Surgical, INC. | $1,363.47 | 2019-2022 | |
| Axonics, INC. | $889.62 | 2020-2024 | Axonics |
| Davol INC. | $566.75 | 2019-2025 | Arista, Phasix Mesh |
| Conmed Corporation | $448.84 | 2019-2022 | |
| Thd America, INC. | $386.17 | 2024-2025 | |
| Ethicon US, LLC | $375.21 | 2023-2025 | Harmonic, Echelon Flex, Enseal |
| Acera Surgical, INC. | $322.71 | 2025 | Restrata Wound Matrix |
| Innovation Technologies INC | $249.83 | 2019-2024 | Irrisept |
| Baxter Healthcare | $244.75 | 2021-2025 | Perclot |
| Medtronic, INC. | $236.03 | 2023-2025 | Interstim, Ligasure |
| Aroa Biosurgery Incorporated | $209.87 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $153.18 | 2019-2021 | |
| Dilon Technologies, INC. | $149.63 | 2024 | Hemoblast Bellows |
| Allergan, INC. | $117.67 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $112.03 | 2025 | |
| Medical Device Business Services, INC. | $101.31 | 2021 | |
| Solventum Corporation | $85.70 | 2025 | Prevena, V.A.C. Veraflo Cleanse Choice, V.A.C.Ulta |
| Eisai INC. | $24.33 | 2020 | |
| Seagen INC. | $20.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Gantt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.